0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microneedle-based Drug Delivery System Market Research Report 2026
Published Date: 2026-01-10
|
Report Code: QYRE-Auto-18M8264
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Microneedle based Drug Delivery System Market Insights Forecast to 2028
BUY CHAPTERS

Global Microneedle-based Drug Delivery System Market Research Report 2026

Code: QYRE-Auto-18M8264
Report
2026-01-10
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Microneedle-based Drug Delivery System Market Size

The global Microneedle-based Drug Delivery System market was valued at US$ 405 million in 2025 and is anticipated to reach US$ 640 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Microneedle-based Drug Delivery System Market

Microneedle-based Drug Delivery System Market

Microneedle-based drug delivery systems are skin-applied devices that use arrays of microscopic needles to cross the outer skin barrier and deliver medicines into the superficial skin layers with minimal pain. They are often classified as soluble microneedle systems—where the needles are made from dissolvable/biodegradable materials that encapsulate the drug and dissolve in the skin to release the dose—and insoluble microneedle systems—where the needles remain intact (e.g., solid or hollow structures) and deliver drug by creating microchannels for topical diffusion, by carrying a surface coating that detaches after insertion, or by infusing liquid formulations through the needle lumen. Consumer/cosmetic microneedle-based drug delivery systems typically cost between $0.75 and $1.60 per patch. Vaccine microneedle-based drug delivery systems cost between $0.85 and $5.00 per dose/patch.
Microneedle-based drug delivery systems sit at the intersection of transdermal device manufacturing and drug-product supply. Upstream inputs include microneedle substrate materials (e.g., medical polymers, sugars/hydrogels for dissolving tips, metals/ceramics for solid arrays), drug substance or vaccine antigen plus stabilizing excipients, precision tooling (micro-molds, etching/laser micromachining equipment), and cleanroom-grade converting materials (backing films, pressure-sensitive adhesives, release liners, desiccants, foil pouches). Manufacturing typically combines microstructure fabrication (molding/etching/printing), drug loading or tip casting/coating, controlled drying and moisture management, assembly/lamination, packaging, and extensive in-process and release testing (dose uniformity, mechanical strength/insertion performance, bioburden/sterility approach, stability). Downstream, microneedle-based drug delivery systems move through clinical-supply and commercial supply chains that resemble combination products: they require device + drug regulatory quality systems, validated packaging and distribution (often with humidity control), and channels that range from mass retail (cosmetic “microdart” patches) to healthcare procurement for vaccines/therapeutics; end-use workflows may include self-administration with minimal training, or administration protocols with applicators and traceability in immunization programs.
The Microneedle-based Drug Delivery System market is developing along two tracks: consumer skincare patches are already commercial and help normalize the form factor, while pharma/vaccine MAPs are advancing through clinical development and manufacturing scale-up as companies pursue easier administration, better patient acceptance, and potential reductions in cold-chain and sharps waste depending on formulation. Near-term competition is centered on platform performance (reliable skin penetration and dose delivery), manufacturability (high-throughput, low-defect microfabrication and drug-loading yields), and regulatory readiness for combination products, which together create high barriers to entry and favor a small set of platform owners and CDMOs. Adoption tends to be indication-specific: Microneedle-based Drug Delivery System are most compelling where adherence, ease of use, and decentralized delivery matter (vaccination campaigns, chronic self-injected biologics, pediatric use), but they must compete against improved autoinjectors, nasal/oral alternatives, and established transdermal systems. Over the next several years, the key market inflection will be successful late-stage trials and the first large-scale approvals that validate cost, stability, and real-world usability—unlocking broader partnering, capacity investment, and standardized manufacturing/quality expectations across the ecosystem.
This report delivers a comprehensive overview of the global Microneedle-based Drug Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microneedle-based Drug Delivery System. The Microneedle-based Drug Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microneedle-based Drug Delivery System market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microneedle-based Drug Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Microneedle-based Drug Delivery System Market Report

Report Metric Details
Report Name Microneedle-based Drug Delivery System Market
Accounted market size in 2025 US$ 405 million
Forecasted market size in 2032 US$ 640 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Dissolving
  • Non-dissolving
Segment by Microneedle Material
  • Hyaluronic Acid
  • Taurine
  • PGA, PLA, PP
Segment by Form of Use
  • Patches
  • Direct Topical
Segment by Application
  • Medical
  • Cosmetics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Microneedle-based Drug Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Microneedle-based Drug Delivery System Market growing?

Ans: The Microneedle-based Drug Delivery System Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Microneedle-based Drug Delivery System Market size in 2032?

Ans: The Microneedle-based Drug Delivery System Market size in 2032 will be US$ 640 million.

Who are the main players in the Microneedle-based Drug Delivery System Market report?

Ans: The main players in the Microneedle-based Drug Delivery System Market are Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical

What are the Application segmentation covered in the Microneedle-based Drug Delivery System Market report?

Ans: The Applications covered in the Microneedle-based Drug Delivery System Market report are Medical, Cosmetics

What are the Type segmentation covered in the Microneedle-based Drug Delivery System Market report?

Ans: The Types covered in the Microneedle-based Drug Delivery System Market report are Dissolving, Non-dissolving

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microneedle-based Drug Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Dissolving
1.2.3 Non-dissolving
1.3 Market by Microneedle Material
1.3.1 Global Microneedle-based Drug Delivery System Market Size Growth Rate by Microneedle Material: 2021 vs 2025 vs 2032
1.3.2 Hyaluronic Acid
1.3.3 Taurine
1.3.4 PGA, PLA, PP
1.4 Market by Form of Use
1.4.1 Global Microneedle-based Drug Delivery System Market Size Growth Rate by Form of Use: 2021 vs 2025 vs 2032
1.4.2 Patches
1.4.3 Direct Topical
1.5 Market by Application
1.5.1 Global Microneedle-based Drug Delivery System Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Medical
1.5.3 Cosmetics
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Microneedle-based Drug Delivery System Market Perspective (2021–2032)
2.2 Global Microneedle-based Drug Delivery System Growth Trends by Region
2.2.1 Global Microneedle-based Drug Delivery System Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microneedle-based Drug Delivery System Historic Market Size by Region (2021–2026)
2.2.3 Microneedle-based Drug Delivery System Forecasted Market Size by Region (2027–2032)
2.3 Microneedle-based Drug Delivery System Market Dynamics
2.3.1 Microneedle-based Drug Delivery System Industry Trends
2.3.2 Microneedle-based Drug Delivery System Market Drivers
2.3.3 Microneedle-based Drug Delivery System Market Challenges
2.3.4 Microneedle-based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microneedle-based Drug Delivery System Players by Revenue
3.1.1 Global Top Microneedle-based Drug Delivery System Players by Revenue (2021–2026)
3.1.2 Global Microneedle-based Drug Delivery System Revenue Market Share by Players (2021–2026)
3.2 Global Top Microneedle-based Drug Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microneedle-based Drug Delivery System Revenue
3.4 Global Microneedle-based Drug Delivery System Market Concentration Ratio
3.4.1 Global Microneedle-based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microneedle-based Drug Delivery System Revenue in 2025
3.5 Global Key Players of Microneedle-based Drug Delivery System Head Offices and Areas Served
3.6 Global Key Players of Microneedle-based Drug Delivery System, Products and Applications
3.7 Global Key Players of Microneedle-based Drug Delivery System, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microneedle-based Drug Delivery System Breakdown Data by Type
4.1 Global Microneedle-based Drug Delivery System Historic Market Size by Type (2021–2026)
4.2 Global Microneedle-based Drug Delivery System Forecasted Market Size by Type (2027–2032)
5 Microneedle-based Drug Delivery System Breakdown Data by Application
5.1 Global Microneedle-based Drug Delivery System Historic Market Size by Application (2021–2026)
5.2 Global Microneedle-based Drug Delivery System Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microneedle-based Drug Delivery System Market Size (2021–2032)
6.2 North America Microneedle-based Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microneedle-based Drug Delivery System Market Size by Country (2021–2026)
6.4 North America Microneedle-based Drug Delivery System Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microneedle-based Drug Delivery System Market Size (2021–2032)
7.2 Europe Microneedle-based Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microneedle-based Drug Delivery System Market Size by Country (2021–2026)
7.4 Europe Microneedle-based Drug Delivery System Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microneedle-based Drug Delivery System Market Size (2021–2032)
8.2 Asia-Pacific Microneedle-based Drug Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microneedle-based Drug Delivery System Market Size by Region (2021–2026)
8.4 Asia-Pacific Microneedle-based Drug Delivery System Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microneedle-based Drug Delivery System Market Size (2021–2032)
9.2 Latin America Microneedle-based Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microneedle-based Drug Delivery System Market Size by Country (2021–2026)
9.4 Latin America Microneedle-based Drug Delivery System Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microneedle-based Drug Delivery System Market Size (2021–2032)
10.2 Middle East & Africa Microneedle-based Drug Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microneedle-based Drug Delivery System Market Size by Country (2021–2026)
10.4 Middle East & Africa Microneedle-based Drug Delivery System Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kindeva
11.1.1 Kindeva Company Details
11.1.2 Kindeva Business Overview
11.1.3 Kindeva Microneedle-based Drug Delivery System Introduction
11.1.4 Kindeva Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.1.5 Kindeva Recent Development
11.2 Raphas
11.2.1 Raphas Company Details
11.2.2 Raphas Business Overview
11.2.3 Raphas Microneedle-based Drug Delivery System Introduction
11.2.4 Raphas Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.2.5 Raphas Recent Development
11.3 CosMED Pharmaceutical
11.3.1 CosMED Pharmaceutical Company Details
11.3.2 CosMED Pharmaceutical Business Overview
11.3.3 CosMED Pharmaceutical Microneedle-based Drug Delivery System Introduction
11.3.4 CosMED Pharmaceutical Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.3.5 CosMED Pharmaceutical Recent Development
11.4 Vaxess Technologies
11.4.1 Vaxess Technologies Company Details
11.4.2 Vaxess Technologies Business Overview
11.4.3 Vaxess Technologies Microneedle-based Drug Delivery System Introduction
11.4.4 Vaxess Technologies Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.4.5 Vaxess Technologies Recent Development
11.5 Micron Biomedical
11.5.1 Micron Biomedical Company Details
11.5.2 Micron Biomedical Business Overview
11.5.3 Micron Biomedical Microneedle-based Drug Delivery System Introduction
11.5.4 Micron Biomedical Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.5.5 Micron Biomedical Recent Development
11.6 LTS Lohmann Therapie-Systeme
11.6.1 LTS Lohmann Therapie-Systeme Company Details
11.6.2 LTS Lohmann Therapie-Systeme Business Overview
11.6.3 LTS Lohmann Therapie-Systeme Microneedle-based Drug Delivery System Introduction
11.6.4 LTS Lohmann Therapie-Systeme Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.6.5 LTS Lohmann Therapie-Systeme Recent Development
11.7 ArrayPatch
11.7.1 ArrayPatch Company Details
11.7.2 ArrayPatch Business Overview
11.7.3 ArrayPatch Microneedle-based Drug Delivery System Introduction
11.7.4 ArrayPatch Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.7.5 ArrayPatch Recent Development
11.8 CeraVx
11.8.1 CeraVx Company Details
11.8.2 CeraVx Business Overview
11.8.3 CeraVx Microneedle-based Drug Delivery System Introduction
11.8.4 CeraVx Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.8.5 CeraVx Recent Development
11.9 Zhongke Microneedle (Beijing) Technology
11.9.1 Zhongke Microneedle (Beijing) Technology Company Details
11.9.2 Zhongke Microneedle (Beijing) Technology Business Overview
11.9.3 Zhongke Microneedle (Beijing) Technology Microneedle-based Drug Delivery System Introduction
11.9.4 Zhongke Microneedle (Beijing) Technology Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.9.5 Zhongke Microneedle (Beijing) Technology Recent Development
11.10 Zhuhai Youwe Biotechnology
11.10.1 Zhuhai Youwe Biotechnology Company Details
11.10.2 Zhuhai Youwe Biotechnology Business Overview
11.10.3 Zhuhai Youwe Biotechnology Microneedle-based Drug Delivery System Introduction
11.10.4 Zhuhai Youwe Biotechnology Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.10.5 Zhuhai Youwe Biotechnology Recent Development
11.11 Youwei (Zhuhai) Biotechnology
11.11.1 Youwei (Zhuhai) Biotechnology Company Details
11.11.2 Youwei (Zhuhai) Biotechnology Business Overview
11.11.3 Youwei (Zhuhai) Biotechnology Microneedle-based Drug Delivery System Introduction
11.11.4 Youwei (Zhuhai) Biotechnology Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.11.5 Youwei (Zhuhai) Biotechnology Recent Development
11.12 WCC Biomedical
11.12.1 WCC Biomedical Company Details
11.12.2 WCC Biomedical Business Overview
11.12.3 WCC Biomedical Microneedle-based Drug Delivery System Introduction
11.12.4 WCC Biomedical Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.12.5 WCC Biomedical Recent Development
11.13 Hisamitsu Pharmaceutical
11.13.1 Hisamitsu Pharmaceutical Company Details
11.13.2 Hisamitsu Pharmaceutical Business Overview
11.13.3 Hisamitsu Pharmaceutical Microneedle-based Drug Delivery System Introduction
11.13.4 Hisamitsu Pharmaceutical Revenue in Microneedle-based Drug Delivery System Business (2021–2026)
11.13.5 Hisamitsu Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Microneedle-based Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Dissolving
 Table 3. Key Players of Non-dissolving
 Table 4. Global Microneedle-based Drug Delivery System Market Size Growth Rate by Microneedle Material (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Key Players of Hyaluronic Acid
 Table 6. Key Players of Taurine
 Table 7. Key Players of PGA, PLA, PP
 Table 8. Global Microneedle-based Drug Delivery System Market Size Growth Rate by Form of Use (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Key Players of Patches
 Table 10. Key Players of Direct Topical
 Table 11. Global Microneedle-based Drug Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 12. Global Microneedle-based Drug Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 13. Global Microneedle-based Drug Delivery System Market Size by Region (US$ Million), 2021–2026
 Table 14. Global Microneedle-based Drug Delivery System Market Share by Region (2021–2026)
 Table 15. Global Microneedle-based Drug Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 16. Global Microneedle-based Drug Delivery System Market Share by Region (2027–2032)
 Table 17. Microneedle-based Drug Delivery System Market Trends
 Table 18. Microneedle-based Drug Delivery System Market Drivers
 Table 19. Microneedle-based Drug Delivery System Market Challenges
 Table 20. Microneedle-based Drug Delivery System Market Restraints
 Table 21. Global Microneedle-based Drug Delivery System Revenue by Players (US$ Million), 2021–2026
 Table 22. Global Microneedle-based Drug Delivery System Market Share by Players (2021–2026)
 Table 23. Global Top Microneedle-based Drug Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microneedle-based Drug Delivery System Revenue, 2025
 Table 24. Ranking of Global Top Microneedle-based Drug Delivery System Companies by Revenue (US$ Million) in 2025
 Table 25. Global 5 Largest Players Market Share by Microneedle-based Drug Delivery System Revenue (CR5 and HHI), 2021–2026
 Table 26. Global Key Players of Microneedle-based Drug Delivery System, Headquarters and Area Served
 Table 27. Global Key Players of Microneedle-based Drug Delivery System, Products and Applications
 Table 28. Global Key Players of Microneedle-based Drug Delivery System, Date of General Availability (GA)
 Table 29. Mergers and Acquisitions, Expansion Plans
 Table 30. Global Microneedle-based Drug Delivery System Market Size by Type (US$ Million), 2021–2026
 Table 31. Global Microneedle-based Drug Delivery System Revenue Market Share by Type (2021–2026)
 Table 32. Global Microneedle-based Drug Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 33. Global Microneedle-based Drug Delivery System Revenue Market Share by Type (2027–2032)
 Table 34. Global Microneedle-based Drug Delivery System Market Size by Application (US$ Million), 2021–2026
 Table 35. Global Microneedle-based Drug Delivery System Revenue Market Share by Application (2021–2026)
 Table 36. Global Microneedle-based Drug Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 37. Global Microneedle-based Drug Delivery System Revenue Market Share by Application (2027–2032)
 Table 38. North America Microneedle-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 39. North America Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2021–2026
 Table 40. North America Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2027–2032
 Table 41. Europe Microneedle-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Europe Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2021–2026
 Table 43. Europe Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2027–2032
 Table 44. Asia-Pacific Microneedle-based Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Asia-Pacific Microneedle-based Drug Delivery System Market Size by Region (US$ Million), 2021–2026
 Table 46. Asia-Pacific Microneedle-based Drug Delivery System Market Size by Region (US$ Million), 2027–2032
 Table 47. Latin America Microneedle-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 48. Latin America Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2021–2026
 Table 49. Latin America Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2027–2032
 Table 50. Middle East & Africa Microneedle-based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 51. Middle East & Africa Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2021–2026
 Table 52. Middle East & Africa Microneedle-based Drug Delivery System Market Size by Country (US$ Million), 2027–2032
 Table 53. Kindeva Company Details
 Table 54. Kindeva Business Overview
 Table 55. Kindeva Microneedle-based Drug Delivery System Product
 Table 56. Kindeva Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 57. Kindeva Recent Development
 Table 58. Raphas Company Details
 Table 59. Raphas Business Overview
 Table 60. Raphas Microneedle-based Drug Delivery System Product
 Table 61. Raphas Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 62. Raphas Recent Development
 Table 63. CosMED Pharmaceutical Company Details
 Table 64. CosMED Pharmaceutical Business Overview
 Table 65. CosMED Pharmaceutical Microneedle-based Drug Delivery System Product
 Table 66. CosMED Pharmaceutical Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 67. CosMED Pharmaceutical Recent Development
 Table 68. Vaxess Technologies Company Details
 Table 69. Vaxess Technologies Business Overview
 Table 70. Vaxess Technologies Microneedle-based Drug Delivery System Product
 Table 71. Vaxess Technologies Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 72. Vaxess Technologies Recent Development
 Table 73. Micron Biomedical Company Details
 Table 74. Micron Biomedical Business Overview
 Table 75. Micron Biomedical Microneedle-based Drug Delivery System Product
 Table 76. Micron Biomedical Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 77. Micron Biomedical Recent Development
 Table 78. LTS Lohmann Therapie-Systeme Company Details
 Table 79. LTS Lohmann Therapie-Systeme Business Overview
 Table 80. LTS Lohmann Therapie-Systeme Microneedle-based Drug Delivery System Product
 Table 81. LTS Lohmann Therapie-Systeme Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 82. LTS Lohmann Therapie-Systeme Recent Development
 Table 83. ArrayPatch Company Details
 Table 84. ArrayPatch Business Overview
 Table 85. ArrayPatch Microneedle-based Drug Delivery System Product
 Table 86. ArrayPatch Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 87. ArrayPatch Recent Development
 Table 88. CeraVx Company Details
 Table 89. CeraVx Business Overview
 Table 90. CeraVx Microneedle-based Drug Delivery System Product
 Table 91. CeraVx Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 92. CeraVx Recent Development
 Table 93. Zhongke Microneedle (Beijing) Technology Company Details
 Table 94. Zhongke Microneedle (Beijing) Technology Business Overview
 Table 95. Zhongke Microneedle (Beijing) Technology Microneedle-based Drug Delivery System Product
 Table 96. Zhongke Microneedle (Beijing) Technology Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 97. Zhongke Microneedle (Beijing) Technology Recent Development
 Table 98. Zhuhai Youwe Biotechnology Company Details
 Table 99. Zhuhai Youwe Biotechnology Business Overview
 Table 100. Zhuhai Youwe Biotechnology Microneedle-based Drug Delivery System Product
 Table 101. Zhuhai Youwe Biotechnology Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 102. Zhuhai Youwe Biotechnology Recent Development
 Table 103. Youwei (Zhuhai) Biotechnology Company Details
 Table 104. Youwei (Zhuhai) Biotechnology Business Overview
 Table 105. Youwei (Zhuhai) Biotechnology Microneedle-based Drug Delivery System Product
 Table 106. Youwei (Zhuhai) Biotechnology Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 107. Youwei (Zhuhai) Biotechnology Recent Development
 Table 108. WCC Biomedical Company Details
 Table 109. WCC Biomedical Business Overview
 Table 110. WCC Biomedical Microneedle-based Drug Delivery System Product
 Table 111. WCC Biomedical Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 112. WCC Biomedical Recent Development
 Table 113. Hisamitsu Pharmaceutical Company Details
 Table 114. Hisamitsu Pharmaceutical Business Overview
 Table 115. Hisamitsu Pharmaceutical Microneedle-based Drug Delivery System Product
 Table 116. Hisamitsu Pharmaceutical Revenue in Microneedle-based Drug Delivery System Business (US$ Million), 2021–2026
 Table 117. Hisamitsu Pharmaceutical Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Microneedle-based Drug Delivery System Picture
 Figure 2. Global Microneedle-based Drug Delivery System Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Microneedle-based Drug Delivery System Market Share by Type: 2025 vs 2032
 Figure 4. Dissolving Features
 Figure 5. Non-dissolving Features
 Figure 6. Global Microneedle-based Drug Delivery System Market Size Comparison by Microneedle Material (US$ Million), 2021–2032
 Figure 7. Hyaluronic Acid Features
 Figure 8. Taurine Features
 Figure 9. PGA, PLA, PP Features
 Figure 10. Global Microneedle-based Drug Delivery System Market Size Comparison by Form of Use (US$ Million), 2021–2032
 Figure 11. Patches Features
 Figure 12. Direct Topical Features
 Figure 13. Global Microneedle-based Drug Delivery System Market Size by Application (US$ Million), 2021–2032
 Figure 14. Global Microneedle-based Drug Delivery System Market Share by Application: 2025 vs 2032
 Figure 15. Medical Case Studies
 Figure 16. Cosmetics Case Studies
 Figure 17. Microneedle-based Drug Delivery System Report Years Considered
 Figure 18. Global Microneedle-based Drug Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 19. Global Microneedle-based Drug Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Microneedle-based Drug Delivery System Market Share by Region: 2025 vs 2032
 Figure 21. Global Microneedle-based Drug Delivery System Market Share by Players in 2025
 Figure 22. Global Microneedle-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 23. The Top 10 and 5 Players Market Share by Microneedle-based Drug Delivery System Revenue in 2025
 Figure 24. North America Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. North America Microneedle-based Drug Delivery System Market Share by Country (2021–2032)
 Figure 26. United States Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Canada Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Microneedle-based Drug Delivery System Market Share by Country (2021–2032)
 Figure 30. Germany Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. France Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. U.K. Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Italy Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Russia Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Ireland Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Microneedle-based Drug Delivery System Market Share by Region (2021–2032)
 Figure 38. China Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Japan Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. South Korea Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Southeast Asia Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. India Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Australia & New Zealand Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Microneedle-based Drug Delivery System Market Share by Country (2021–2032)
 Figure 46. Mexico Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Brazil Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Microneedle-based Drug Delivery System Market Share by Country (2021–2032)
 Figure 50. Israel Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. UAE Microneedle-based Drug Delivery System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Kindeva Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 54. Raphas Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 55. CosMED Pharmaceutical Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 56. Vaxess Technologies Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 57. Micron Biomedical Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 58. LTS Lohmann Therapie-Systeme Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 59. ArrayPatch Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 60. CeraVx Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 61. Zhongke Microneedle (Beijing) Technology Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 62. Zhuhai Youwe Biotechnology Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 63. Youwei (Zhuhai) Biotechnology Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 64. WCC Biomedical Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 65. Hisamitsu Pharmaceutical Revenue Growth Rate in Microneedle-based Drug Delivery System Business (2021–2026)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS